Items where authors include "Arlt, W."

Article

Rees, A.D., Merke, D.P., Arlt, W. et al. (12 more authors) (2024) Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia. Endocrine Connections, 13 (8). e240150. ISSN 2049-3614

Pelsma, I.C.M. orcid.org/0000-0003-4956-4037, Fassnacht, M. orcid.org/0000-0001-6170-6398, Tsagarakis, S. orcid.org/0000-0003-1959-8738 et al. (9 more authors) (2023) Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. European Journal of Endocrinology, 189 (4). S88-S101. ISSN 0804-4643

Fassnacht, M. orcid.org/0000-0001-6170-6398, Tsagarakis, S., Terzolo, M. orcid.org/0000-0002-4171-2851 et al. (9 more authors) (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology, 189 (1). G1-G42. ISSN 0804-4643

Tschaidse, L., Reisch, N. orcid.org/0000-0002-7469-6069, Arlt, W. orcid.org/0000-0001-5106-9719 et al. (15 more authors) (2023) Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia. European Journal of Endocrinology, 188 (1). lvac006. pp. 109-117. ISSN 0804-4643

Sun, M., Mueller, J.W., Gilligan, L.C. et al. (15 more authors) (2021) The broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency : a case series. European Journal of Endocrinology, 185 (5). pp. 729-741. ISSN 0804-4643

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2021) Modified-release hydrocortisone in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism, 106 (5). e2063-e2077. ISSN 0021-972X

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2020) OR25-02 A phase 3 study of a modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia. Journal of the Endocrine Society, 4 (Supplement_1).

Nikolaou, N., Arvaniti, A., Appanna, N. et al. (13 more authors) (2020) Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo. Journal of Endocrinology, 245 (2). pp. 207-218. ISSN 0022-0795

Reisch, N., Taylor, A.E., Nogueira, E.F. et al. (8 more authors) (2019) Alternative pathway androgen biosynthesis and human fetal female virilization. Proceedings of the National Academy of Sciences, 116 (44). pp. 22294-22299. ISSN 0027-8424

Idkowiak, J., Elhassan, Y.S., Mannion, P. et al. (13 more authors) (2019) Causes, patterns and severity of androgen excess in 487 consecutively recruited pre- and post-pubertal children. European Journal of Endocrinology, 180 (3). pp. 213-221. ISSN 0804-4643

Webb, E.A., Elliott, L., Carlin, D. et al. (11 more authors) (2018) Quantitative MRI brain in congenital adrenal hyperplasia: in vivo assessment of the cognitive and structural impact of steroid hormones. Journal of Clinical Endocrinology and Metabolism, 103 (4). pp. 1330-1341. ISSN 0021-972X

Jones, C.M., Mallappa, A., Reisch, N. et al. (10 more authors) (2016) Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism. jc20162855. ISSN 0021-972X

Ahmed, S.F., Achermann, J.C., Arlt, W. et al. (14 more authors) (2016) Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015). Clinical Endocrinology, 84 (5). pp. 771-788. ISSN 0300-0664

Debono, M., Harrison, R.F., Whitaker, M.J. et al. (4 more authors) (2016) Salivary Cortisone Reflects Cortisol Exposure Under Physiological Conditions and After Hydrocortisone. The Journal of Clinical Endocrinology & Metabolism, 101 (4). pp. 1469-1477. ISSN 0021-972X

Whitaker, M.J., Debono, M., Huatan, H. et al. (3 more authors) (2014) An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure. Clinical Endocrinology, 80 (4). pp. 554-561. ISSN 0300-0664

Han, T.S., Krone, N. orcid.org/0000-0002-3402-4727, Willis, D.S. et al. (8 more authors) (2013) Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). EUROPEAN JOURNAL OF ENDOCRINOLOGY, 168 (6). pp. 887-893. ISSN 0804-4643

Parajes, S., Chan, A.O.K., But, W.M. et al. (5 more authors) (2012) Delayed diagnosis of adrenal insufficiency in a patient with severe penoscrotal hypospadias due to two novel P450 side-change cleavage enzyme (CYP11A1) mutations (p.R360W; p.R405X). European Journal of Endocrinology, 167 (6). pp. 881-885. ISSN 0804-4643

Debono, M., Ghobadi, C., Rostami-Hodjegan, A. et al. (7 more authors) (2009) Modified-release hydrocortisone to provide circadian cortisol profiles. Journal of Clinical Endocrinology and Metabolism, 94 (5). pp. 1548-1554. ISSN 0021-972X

Proceedings Paper

Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (13 more authors) (2024) 12670 CHAMPAIN study: initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Lawrence, N.R. orcid.org/0000-0002-7560-0268, Krone, N.P., Dawson, J.F. et al. (15 more authors) (2024) 6437 Analysis of 17-OH-progesterone (17OHP) and androstenedione (A4) profiles to rationalise biochemical monitoring of CAH patients. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Ross, R.J.M., Merke, D.P., Mallappa, A. et al. (14 more authors) (2024) 7061 Incidence of adrenal crisis in Congenital Adrenal Hyperplasia (CAH) patients during a prospective monitored long-term study of modified-release hydrocortisone (MRHC) capsules, (Efmody). In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (13 more authors) (2024) 7692 Morning cortisol levels in patients with established primary adrenal insufficiency. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .

Prete, A., Theiler-Schwetz, V., Arlt, W. et al. (13 more authors) (2024) 9341 CHAMPAIN Study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .